產(chǎn)品詳情
簡單介紹：
Anti-ETV2抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗抗體。Anti-ETV2抗體用于**組化實(shí)驗,WB實(shí)驗,相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-ETV2
Cat. Number:
Anti-ETV2抗體KL-12341R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
ER71 is a 341 amino acid member of the ETS protein family. Localized to the nucleus, ER71 contains one ETS DNA-binding domain which binds to DNA sequences containing the consensus pentanucleotide 5'-CGGA[AT]-3'.Anti-ETV2抗體 The gene encoding ER71 maps to human chromosome 19, which consists of around 63 million bases with over 1,400 genes, making up over 2% of human genomic DNA. Chromosome 19 is recognized for having the greatest gene density of the human chromosomes. It is the genetic home for a number of immunoglobulin superfamily members, including the killer cell and leukocyte Ig-like receptors, a number of ICAMs, the CEACAM and PSG family and Fc?receptors. Key genes for eye color and hair color also map to chromosome 19. Peutz-Jeghers syndrome, spinocerebellar ataxia type 6, the stroke disorder CADASIL, hypercholesterolemia and insulin-dependent diabetes have been linked to chromosome 19. Translocations with chromosome 19 and chromosome 14 can be seen in some lymphoproliferative disorders and typically involve the proto-oncogene BCL3.
Also known as:
ER71; Ets related protein 71; Anti-ETV2抗體ETS translocation variant 2; Ets variant gene 2; Ets-related protein 71; ETSRP71; ETV2_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from Human ETV2/ER7.
●
Predicted Molecular Weight: Anti-ETV2抗體37kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:50-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-ETV2抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-ETV2抗體
Optimal working dilutions must be determined by the end user.
kl464Ra01 鹽皮質(zhì)**受體(MR)多克隆抗體 Polyclonal Antibody to Mineralocorticoid Receptor (MR)
kl468Hu01 衰變加速因子(DAF)多克隆抗體 Polyclonal Antibody to Decay Accelerating Factor (DAF)
kl470Hu01 熱休克轉(zhuǎn)錄因子2(HSF2)多克隆抗體 Polyclonal Antibody to Heat Shock Transcription Factor 2 (HSF2)
kl471Bo01 骨鈣素(OC)多克隆抗體 Polyclonal Antibody to Osteocalcin (OC)
kl471Ca01 骨鈣素(OC)多克隆抗體 Polyclonal Antibody to Osteocalcin (OC)
kl471Hu01 骨鈣素(OC)多克隆抗體 Polyclonal Antibody to Osteocalcin (OC)
kl471Mu01 骨鈣素(OC)多克隆抗體 Polyclonal Antibody to Osteocalcin (OC)
kl471Po01 骨鈣素(OC)多克隆抗體 Polyclonal Antibody to Osteocalcin (OC)
kl471Ra01 骨鈣素(OC)多克隆抗體 Polyclonal Antibody to Osteocalcin (OC)
kl471Rb51 骨鈣素(OC)多克隆抗體 Polyclonal Antibody to Osteocalcin (OC)
kl472Ca01 降鈣素(CT)多克隆抗體 Polyclonal Antibody to Calcitonin (CT)
kl472Hu01 降鈣素(CT)多克隆抗體 Polyclonal Antibody to Calcitonin (CT)
kl472Mu01 降鈣素(CT)多克隆抗體 Polyclonal Antibody to Calcitonin (CT)
kl472Ra01 降鈣素(CT)多克隆抗體 Polyclonal Antibody to Calcitonin (CT)
kl473Hu01 C組著色性干皮病偶聯(lián)因子(XPC)多克隆抗體 Polyclonal Antibody to Xeroderma Pigmentosum, Complementation Group C (XPC)
kl473Mu01 C組著色性干皮病偶聯(lián)因子(XPC)多克隆抗體 Polyclonal Antibody to Xeroderma Pigmentosum, Complementation Group C (XPC)
kl474Hu01 甲狀旁腺素受體2(PTHR2)多克隆抗體 Polyclonal Antibody to klathyroid Hormone Receptor 2 (PTHR2)
kl474Ra01 甲狀旁腺素受體2(PTHR2)多克隆抗體 Polyclonal Antibody to klathyroid Hormone Receptor 2 (PTHR2)
